US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist

2.020
+0.175+9.49%

Close Mar 4 16:00 ET

1.850
-0.170-8.42%

Pre 04:47 ET

114.14MMarket Cap-2.13P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.381M	--
--	2024/Q4	-- / 1.510M	--
--	2024/Q3	1.049M / 1.173M	--
--	2024/Q2	536.000K / 1.819M	--
--	2024/Q1	566.000K / 4.300M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.381M--

--2024/Q4-- / 1.510M--

--2024/Q31.049M / 1.173M--

--2024/Q2536.000K / 1.819M--

--2024/Q1566.000K / 4.300M--

Unlock Free Earnings Estimates

Open Account

TScan Therapeutics Earnings Reports

TScan Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 12:26 ET

TScan Therapeutics | 8-K: TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024 12:26 ET

TScan Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 07:35 ET

TScan Therapeutics | 8-K: TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12, 2024 07:20 ET

Trending Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

DMZPY

+2.22%

Unlock the Full List

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data